Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12501885rdf:typepubmed:Citationlld:pubmed
pubmed-article:12501885lifeskim:mentionsumls-concept:C0543467lld:lifeskim
pubmed-article:12501885lifeskim:mentionsumls-concept:C0149871lld:lifeskim
pubmed-article:12501885lifeskim:mentionsumls-concept:C0019139lld:lifeskim
pubmed-article:12501885lifeskim:mentionsumls-concept:C0043031lld:lifeskim
pubmed-article:12501885lifeskim:mentionsumls-concept:C0206460lld:lifeskim
pubmed-article:12501885lifeskim:mentionsumls-concept:C0009566lld:lifeskim
pubmed-article:12501885lifeskim:mentionsumls-concept:C0199176lld:lifeskim
pubmed-article:12501885lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:12501885lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:12501885lifeskim:mentionsumls-concept:C0010181lld:lifeskim
pubmed-article:12501885lifeskim:mentionsumls-concept:C0013554lld:lifeskim
pubmed-article:12501885lifeskim:mentionsumls-concept:C0040508lld:lifeskim
pubmed-article:12501885lifeskim:mentionsumls-concept:C1516048lld:lifeskim
pubmed-article:12501885lifeskim:mentionsumls-concept:C0041703lld:lifeskim
pubmed-article:12501885lifeskim:mentionsumls-concept:C0443252lld:lifeskim
pubmed-article:12501885pubmed:issue11lld:pubmed
pubmed-article:12501885pubmed:dateCreated2002-12-27lld:pubmed
pubmed-article:12501885pubmed:abstractTextPremature death due to pulmonary embolism is a short-term complication of deep vein thrombosis (DVT). The long-term clinical course after DVT can be further complicated by excess mortality, recurrent venous thromboembolism (VTE), and the post-thrombotic syndrome (PTS), which may produce sizable long-term economic burdens.lld:pubmed
pubmed-article:12501885pubmed:languageenglld:pubmed
pubmed-article:12501885pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12501885pubmed:citationSubsetIMlld:pubmed
pubmed-article:12501885pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12501885pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12501885pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12501885pubmed:statusMEDLINElld:pubmed
pubmed-article:12501885pubmed:monthNovlld:pubmed
pubmed-article:12501885pubmed:issn0149-2918lld:pubmed
pubmed-article:12501885pubmed:authorpubmed-author:CohenAlexande...lld:pubmed
pubmed-article:12501885pubmed:authorpubmed-author:PashosChris...lld:pubmed
pubmed-article:12501885pubmed:authorpubmed-author:NadipelliVija...lld:pubmed
pubmed-article:12501885pubmed:authorpubmed-author:BottemanMarc...lld:pubmed
pubmed-article:12501885pubmed:authorpubmed-author:CapriniJoseph...lld:pubmed
pubmed-article:12501885pubmed:authorpubmed-author:StephensJenni...lld:pubmed
pubmed-article:12501885pubmed:authorpubmed-author:BellChristoph...lld:pubmed
pubmed-article:12501885pubmed:issnTypePrintlld:pubmed
pubmed-article:12501885pubmed:volume24lld:pubmed
pubmed-article:12501885pubmed:ownerNLMlld:pubmed
pubmed-article:12501885pubmed:authorsCompleteYlld:pubmed
pubmed-article:12501885pubmed:pagination1960-86; discussion 1938lld:pubmed
pubmed-article:12501885pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12501885pubmed:meshHeadingpubmed-meshheading:12501885...lld:pubmed
pubmed-article:12501885pubmed:meshHeadingpubmed-meshheading:12501885...lld:pubmed
pubmed-article:12501885pubmed:meshHeadingpubmed-meshheading:12501885...lld:pubmed
pubmed-article:12501885pubmed:meshHeadingpubmed-meshheading:12501885...lld:pubmed
pubmed-article:12501885pubmed:meshHeadingpubmed-meshheading:12501885...lld:pubmed
pubmed-article:12501885pubmed:meshHeadingpubmed-meshheading:12501885...lld:pubmed
pubmed-article:12501885pubmed:meshHeadingpubmed-meshheading:12501885...lld:pubmed
pubmed-article:12501885pubmed:meshHeadingpubmed-meshheading:12501885...lld:pubmed
pubmed-article:12501885pubmed:meshHeadingpubmed-meshheading:12501885...lld:pubmed
pubmed-article:12501885pubmed:meshHeadingpubmed-meshheading:12501885...lld:pubmed
pubmed-article:12501885pubmed:meshHeadingpubmed-meshheading:12501885...lld:pubmed
pubmed-article:12501885pubmed:meshHeadingpubmed-meshheading:12501885...lld:pubmed
pubmed-article:12501885pubmed:meshHeadingpubmed-meshheading:12501885...lld:pubmed
pubmed-article:12501885pubmed:meshHeadingpubmed-meshheading:12501885...lld:pubmed
pubmed-article:12501885pubmed:meshHeadingpubmed-meshheading:12501885...lld:pubmed
pubmed-article:12501885pubmed:meshHeadingpubmed-meshheading:12501885...lld:pubmed
pubmed-article:12501885pubmed:meshHeadingpubmed-meshheading:12501885...lld:pubmed
pubmed-article:12501885pubmed:meshHeadingpubmed-meshheading:12501885...lld:pubmed
pubmed-article:12501885pubmed:year2002lld:pubmed
pubmed-article:12501885pubmed:articleTitleResults of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and associated long-term complications in total hip replacement surgery in the United States.lld:pubmed
pubmed-article:12501885pubmed:affiliationInternational Health Economics, HERQuLES, Abt Associates Clinical Trials, Bethesda, Maryland 20814, USA. marc_botteman@abtassoc.comlld:pubmed
pubmed-article:12501885pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12501885pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:12501885pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12501885lld:pubmed